SAR Tag

Sareum Holdings PLC – Final Results

15th October 2019

Sareum Holdings plc (AIM: SAR), the specialised small molecule drug development business, announces its results for the year ended 30 June 2019 and provides an update of significant post-period events....

Sareum Holdings PLC – Trading Statement

27th August 2019

Sareum Holdings plc (AIM: SAR), the specialised small molecule drug development business, provides the following trading update ahead of its full year results for the year ended 30 June 2019....

Sareum Holdings PLC – Successful Fundraising

26th June 2019

Sareum Holdings PLC, the specialist small molecule drug development business announced on 25 June 2019 the launch of a fundraising comprising a placing by Hybridan LLP in conjunction with an offer...

Sareum Holdings PLC – HALF-YEAR RESULTS

4th March 2019

Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, announces its half-yearly results for the six months ended 31 December 2018 and provides an update of...

Sareum Holdings PLC – FINAL RESULTS

1st October 2018

Sareum Holdings plc (AIM: SAR), the specialist in small molecule drug development, announces its results for the year ended 30 June 2018 and provides an update of significant post-period events....

Sareum Holdings PLC – Sareum regains rights to Aurora+FLT3 inhibitors

31st May 2018

Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, announced that it has regained worldwide rights to preclinical-stage small molecule inhibitors of Aurora and FLT3 kinases...

SAR Tag

THE PEBBLE GROUP
5.0

LONGBOAT ENERGY
5.0

Market News

Member Area

Legal